Clinical Trial Update: Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating convalescent plasma for treatment of severe SARS-CoV-2 (COVID-19) is underway with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Disease

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Hospital San Vicente Fundación | Conditions: SARS-Cov-2 | Phase 3 | Status: UNKNOWN